Sinew Pharma Inc. (TPEX:6634)

Sinew Pharma Statistics

Total Valuation

Sinew Pharma has a market cap or net worth of TWD 2.67 billion. The enterprise value is 1.63 billion.

Market Cap	2.67B
Enterprise Value	1.63B

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Sinew Pharma has 71.29 million shares outstanding. The number of shares has decreased by -0.37% in one year.

Current Share Class	71.29M
Shares Outstanding	71.29M
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	17.80%
Owned by Institutions (%)	3.23%
Float	42.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	56,727.79
PB Ratio	2.44
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.98

Financial Position

The company has a current ratio of 42.27, with a Debt / Equity ratio of 0.01.

Current Ratio	42.27
Quick Ratio	42.23
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-213.28

Financial Efficiency

Return on equity (ROE) is -10.81% and return on invested capital (ROIC) is -7.59%.

Return on Equity (ROE)	-10.81%
Return on Assets (ROA)	-7.44%
Return on Invested Capital (ROIC)	-7.59%
Return on Capital Employed (ROCE)	-12.71%
Weighted Average Cost of Capital (WACC)	4.03%
Revenue Per Employee	979
Profits Per Employee	-2.58M
Employee Count	48
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.74% in the last 52 weeks. The beta is -0.04, so Sinew Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-19.74%
50-Day Moving Average	35.09
200-Day Moving Average	42.37
Relative Strength Index (RSI)	66.57
Average Volume (20 Days)	67,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinew Pharma had revenue of TWD 47,000 and -123.75 million in losses. Loss per share was -1.74.

Revenue	47,000
Gross Profit	37,000
Operating Income	-140.13M
Pretax Income	-123.75M
Net Income	-123.75M
EBITDA	-127.14M
EBIT	-140.13M
Loss Per Share	-1.74

Balance Sheet

The company has 1.05 billion in cash and 15.21 million in debt, with a net cash position of 1.04 billion or 14.55 per share.

Cash & Cash Equivalents	1.05B
Total Debt	15.21M
Net Cash	1.04B
Net Cash Per Share	14.55
Equity (Book Value)	1.09B
Book Value Per Share	15.31
Working Capital	1.05B

Cash Flow

In the last 12 months, operating cash flow was -95.30 million and capital expenditures -634,000, giving a free cash flow of -95.93 million.

Operating Cash Flow	-95.30M
Capital Expenditures	-634,000
Depreciation & Amortization	12.99M
Net Borrowing	-6.22M
Free Cash Flow	-95.93M
FCF Per Share	-1.35

Margins

Gross Margin	78.72%
Operating Margin	-298,140.43%
Pretax Margin	-263,287.23%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Sinew Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.37%
Shareholder Yield	0.37%
Earnings Yield	-4.64%
FCF Yield	-3.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sinew Pharma has an Altman Z-Score of 55.92 and a Piotroski F-Score of 1.

Altman Z-Score	55.92
Piotroski F-Score	1